Blood test could signal time to switch cancer drugs before scans show progression
NCT ID NCT05826964
Summary
This study is testing whether switching breast cancer treatment earlier, based on a blood test that detects cancer DNA, helps control the disease longer than waiting for standard scans to show it's getting worse. It involves 24 people with advanced, hormone-positive breast cancer that has spread. Participants are randomly assigned to either switch treatments when the blood test shows early signs of progression or to continue their current treatment until progression is seen on scans.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Miami
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.